| Cancer treatment and survivorship statistics, 2022 KD Miller, L Nogueira, T Devasia, AB Mariotto, KR Yabroff, A Jemal, ... CA: a cancer journal for clinicians 72 (5), 409-436, 2022 | 1212 | 2022 |
| Dose escalation trial of the Wee1 inhibitor adavosertib (AZD1775) in combination with gemcitabine and radiation for patients with locally advanced pancreatic cancer KC Cuneo, MA Morgan, V Sahai, MJ Schipper, LA Parsels, JD Parsels, ... Journal of Clinical Oncology 37 (29), 2643, 2019 | 147 | 2019 |
| Integrated survival estimates for cancer treatment delay among adults with cancer during the COVID-19 pandemic HE Hartman, Y Sun, TP Devasia, EC Chase, NK Jairath, RT Dess, ... JAMA oncology 6 (12), 1881-1889, 2020 | 89 | 2020 |
| Estimation of the number of individuals living with metastatic cancer in the United States L Gallicchio, TP Devasia, E Tonorezos, MA Mollica, A Mariotto JNCI: Journal of the National Cancer Institute 114 (11), 1476-1483, 2022 | 68 | 2022 |
| Prediction of tumor control in 90Y radioembolization by logit models with PET/CT-based dose metrics YK Dewaraja, T Devasia, RK Kaza, JK Mikell, D Owen, PL Roberson, ... Journal of Nuclear Medicine 61 (1), 104-111, 2020 | 44 | 2020 |
| A novel time–activity information-sharing approach using nonlinear mixed models for patient-specific dosimetry with reduced imaging time points: Application in SPECT/CT after … TP Devasia, YK Dewaraja, KA Frey, KK Wong, MJ Schipper Journal of Nuclear Medicine 62 (8), 1118-1125, 2021 | 38 | 2021 |
| Natural history of hepatocellular carcinoma after stereotactic body radiation therapy M Mendiratta-Lala, W Masch, D Owen, A Aslam, C Maurino, T Devasia, ... Abdominal Radiology 45, 3698-3708, 2020 | 24 | 2020 |
| Serum levels of hepatocyte growth factor and CD40 ligand predict radiation-induced liver injury KC Cuneo, T Devasia, Y Sun, MJ Schipper, D Karnak, MA Davis, D Owen, ... Translational Oncology 12 (7), 889-894, 2019 | 19 | 2019 |
| TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapy MM Cousins, E Morris, C Maurino, TP Devasia, D Karnak, D Ray, ... Translational oncology 14 (1), 100950, 2021 | 16 | 2021 |
| Low-dose Hsp90 inhibitor selectively radiosensitizes HNSCC and pancreatic xenografts RK Mehta, S Pal, K Kondapi, M Sitto, C Dewar, T Devasia, MJ Schipper, ... Clinical Cancer Research 26 (19), 5246-5257, 2020 | 16 | 2020 |
| BRAINSTORM: A multi-institutional phase 1/2 Study of RRx-001 in combination with whole brain radiation therapy for patients with brain metastases MM Kim, HA Parmar, M Schipper, T Devasia, MP Aryal, S Kesari, S O’Day, ... International Journal of Radiation Oncology* Biology* Physics 107 (3), 478-486, 2020 | 10 | 2020 |
| Estimating the number of men living with metastatic prostate cancer in the United States TP Devasia, AB Mariotto, YA Nyame, R Etzioni Cancer Epidemiology, Biomarkers & Prevention 32 (5), 659-665, 2023 | 8 | 2023 |
| Patient-reported sexual aid utilization and efficacy after radiation therapy for localized prostate cancer RT Dess, TP Devasia, N Aghdam, WC Jackson, PD Soni, CP Smith, ... International Journal of Radiation Oncology* Biology* Physics 101 (2), 376-386, 2018 | 7 | 2018 |
| Impact of 90Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization JK Mikell, RK Kaza, PL Roberson, KC Younge, RN Srinivasa, ... EJNMMI physics 5, 1-17, 2018 | 6 | 2018 |
| Cannabis use in patients seen in an academic radiation oncology department MM Cousins, C Mayo, T Devasia, M Dykstra, S Regan, S Miller, SG Allen, ... Practical Radiation Oncology 13 (2), 112-121, 2023 | 5 | 2023 |
| Long-term Cancer Survival Trends by Updated Summary Stage G Forjaz, L Ries, TP Devasia, G Flynn, J Ruhl, AB Mariotto Cancer Epidemiology, Biomarkers & Prevention 32 (11), 1508-1517, 2023 | 2 | 2023 |
| Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel … MM Cousins, TP Devasia, CM Maurino, J Mikell, MJ Schipper, RK Kaza, ... Journal of Nuclear Medicine 63 (6), 882-889, 2022 | 2 | 2022 |
| Increase in the Life Expectancy of Patients with Cancer in the United States TP Devasia, N Howlader, RA Dewar, JL Stevens, K Mittu, AB Mariotto Cancer Epidemiology, Biomarkers & Prevention 33 (2), 196-205, 2024 | 1 | 2024 |
| Pre-treatment sTNFR1 and HGF levels predict toxicity and overall survival after 90Y radioembolization: potential novel application of biomarkers for personalized management of … MM Cousins, TP Devasia, CM Maurino, J Mikell, MJ Schipper, RK Kaza, ... Journal of Nuclear Medicine, 2021 | 1 | 2021 |
| Logistic regression models for accurate prediction of tumor control using radiobiologic dose metrics in Y-90 radioembolization T Devasia, Y Dewaraja, P Roberson, M Schipper Journal of Nuclear Medicine 60 (supplement 1), 120-120, 2019 | 1 | 2019 |
